Alnylam Pharmaceuticals: JPMorgan cuts target price to $369 from $375
ALNY•JPMorgan cut its target price for Alnylam Pharmaceuticals to $369 from $375.
Related News
Arthur J. Gallagher & Co.: Jefferies cuts target price to $295 from $300
AJG•
Commodities intraday targets and key levels
USO•
China's factory activity returns to growth in September as AI boom supports industry
FXI•
YYForce unit wins Singapore facilities services contracts worth S$15.96 million
YFOR•
Indian shares open flat after foreign outflows
INDA•